HY-PHEN Drug Patent Profile
Which patents cover Hy-phen, and when can generic versions of Hy-phen launch?
Hy-phen is a drug marketed by Ascher and is included in one NDA.
The generic ingredient in HY-PHEN is acetaminophen; hydrocodone bitartrate. There is one drug master file entry for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HY-PHEN?
- What are the global sales for HY-PHEN?
- What is Average Wholesale Price for HY-PHEN?
Summary for HY-PHEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 168 |
| Patent Applications: | 661 |
| DailyMed Link: | HY-PHEN at DailyMed |
US Patents and Regulatory Information for HY-PHEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascher | HY-PHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 087677-001 | May 3, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
